- Category
- Micro (2023-24)
- Udyam number
- UDYAM-MH-19-0130285

Broadbill Medicines Private Limited
About Broadbill Medicines Private Limited
Data last updated:
Broadbill Medicines Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 December 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2021PTC374112. Its GSTIN is 27AAKCB4101C1Z9 (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Pankaj Bharat Upadhyay and Vandana Umesh Bhilare.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Mumbai, Maharashtra.
Court records list 5 cases involving the company, including 5 filed against it; 3 cases are pending.
Broadbill Medicines Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0130285). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Broadbill Medicines
Contact details
Broadbill Medicines Private Limited's registered office is in Mumbai, Maharashtra.
- Registered Address6th Floor New Beauty Centre, S V Road Khar West, Mumbai, Maharashtra, India – 400052
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Broadbill Medicines Private Limited
FY 2022 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2021-22 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Broadbill Medicines Private Limited, buy the company report.
Board of directors of Broadbill Medicines Private Limited
Broadbill Medicines has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pankaj Bharat Upadhyay | Director | 05 Apr 2022 | 4 Years 7 Months | Current |
| Vandana Umesh Bhilare Also directs: Flynjoy Global Logitch Private Limited | Director | 30 Dec 2021 | 4 Years 10 Months | Current |
| Umesh Appasaheb Bhilare Also directs: Flynjoy Global Logitch Private Limited | Director | 23 Sep 2022 | 4 Years 1 Months | Current |
Legal cases
Broadbill Medicines Private Limited has 5 court cases on record: 5 filed against it. 3 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 3 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Criminal case | Filed against the company by Pure and Cure Healthcare Pvt Ltd | Pending |
| High Court of Delhi | Arbitration matter | Filed against the company by Akums Drugs and Pharmaceuticals Ltd. | Disposed |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by an individual | Pending |
| District court, Pune, Maharashtra | Court case (R.C.C.) | Filed against the company by an individual | Pending |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by an individual | Disposed |
To see the full case history of Broadbill Medicines Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Broadbill Medicines Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Broadbill Medicines has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAKCB4101C1Z9 | Maharashtra | Active | 24 Feb 2022 |
To see the full GST registrations and return filing status of Broadbill Medicines Private Limited, buy the company report.
Recent activity
Broadbill Medicines Private Limited has 9 board changes on record since 2021: 4 appointments and 5 cessations. The latest: Abdul Khan Ahad Hayat ceased to be Director on 11 Jul 2025.
Frequently asked questions
Broadbill Medicines is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 December 2021 (5+ years old) and is registered under CIN U51909MH2021PTC374112.
Broadbill Medicines has 3 current directors:
- Pankaj Bharat Upadhyay - Director
- Vandana Umesh Bhilare - Director
- Umesh Appasaheb Bhilare - Director
The latest financial statements of Broadbill Medicines on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Broadbill Medicines is 27AAKCB4101C1Z9, registered in Maharashtra.
The CIN (Corporate Identification Number) of Broadbill Medicines is U51909MH2021PTC374112. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Broadbill Medicines has 5 court cases on record: 5 filed against it. 3 are pending. Most are in the district courts.
Broadbill Medicines was incorporated on 30 December 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Abdul Khan Ahad Hayat ceased to be Director on 11 Jul 2025. Mehmood Abdul Qasem Shirazi ceased to be Director on 11 Jul 2025. Mehmood Abdul Qasem Shirazi was appointed as Director on 15 Jan 2025. Broadbill Medicines has 9 board changes on record in total.
Yes, Broadbill Medicines is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0130285).
The registered office of Broadbill Medicines is at 6th Floor New Beauty Centre, S V Road Khar West, Mumbai, Maharashtra, India – 400052.

